Intellectual Property India Publishes Patent Application for 'Composition For Removing Helicobacter Pylori Comprising Zastaprazan Or Pharmaceutically Acceptable Salt Thereof' Filed by Jeil Pharmaceutical Co. Ltd.; and Onconic Therapeutics Inc.

MUMBAI, India, Aug. 8 -- Intellectual Property India has published a patent application (202517060325 A) filed by Jeil Pharmaceutical Co. Ltd.; and Onconic Therapeutics Inc., Seoul, Republic of Korea, on June 24, for 'composition for removing helicobacter pylori comprising zastaprazan or pharmaceutically acceptable salt thereof.'

Inventor(s) include Kim, John; Cha, Hyun Ju; and Han, Sang Woo.

The application for the patent was published on Aug. 8, under issue no. 32/2025.

According to the abstract released by the Intellectual Property India: "Disclosed is a composition for removing Helicobacter pylori, comprising zastaprazan or a pharmaceutically acceptable salt thereof."

The patent application was internationally filed on Nov. 29, 2023, under International application No.PCT/KR2023/019495.

Disclaimer: Curated by HT Syndication.